What is the current market size?

The Veterinary Needle-free Injection Device market size reached USD 1.2 billion in 2023, driven by demand in livestock and companion animal healthcare.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by advancements in needle-free delivery technologies.

What are the key drivers?

Key drivers include rising demand for safer veterinary practices, increasing livestock vaccination needs, and growing pet ownership in emerging economies.

What challenges exist in the market?

Challenges include high device costs, limited awareness among veterinarians, and technical issues like inconsistent dosing in some needle-free systems.

Which regions lead the market?

North America and Europe dominate the market due to advanced veterinary infrastructure, followed by Asia-Pacific with high growth potential.

Who are the top companies?

Leading companies include Ceva Santé Animale, Boehringer Ingelheim, and Zoetis, which focus on R&D and strategic partnerships to strengthen their market position.

What future opportunities exist?

Opportunities lie in expanding into emerging markets, integrating AI for precision dosing, and developing affordable devices for small-scale farmers.

How does technology impact the market?

Technological innovations like high-pressure jet injectors and micro-dosing systems enhance device efficiency, driving adoption in veterinary clinics globally.

What is the regulatory landscape?

Regulatory frameworks by FDA, EMA, and APVMA ensure safety and efficacy, creating barriers for new entrants but fostering trust among end-users.

What is the future outlook?

The market future outlook remains positive, with a focus on sustainability, reduced animal stress, and digital integration to meet evolving veterinary needs.

Veterinary Needle-free Injection Device Growth Analysis & Future Outlook 2033

Veterinary Needle-free Injection Device by Application (Pigs, Cattle, Poultry, Companion Animals, Others), by Types (Battery Powered, Compressed Gas Powered), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Veterinary Needle-free Injection Device Market Overview

The Veterinary Needle-free Injection Device market focuses on innovative drug delivery systems that eliminate needle use, enhancing safety and reducing stress for animals and handlers. As part of the broader Veterinary Needle-free Injection Device market size expansion, the industry is witnessing transformative momentum driven by advancements in industry expansion and regulatory shifts toward animal welfare. With a growth outlook projected at a CAGR of 6.8% (2026–2033), the market is poised to reach USD 470 million by 2033, up from USD 265 million in 2026, reflecting robust market forecast potential.

Loading chart…

Key drivers include rising adoption of minimally invasive veterinary care and stringent regulations on needle-stick injuries. Jet Injectors dominate the market due to precision and scalability, while Pressure Injectors see growth in livestock applications. North America remains the largest regional market, while Asia-Pacific emerges as the fastest-growing segment, fueled by rising pet ownership and infrastructure development. Competitive dynamics are intensifying, with R&D investments in biodegradable materials and AI-driven dose optimization shaping the next phase of industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	592.43 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HIPRA; Merck; Pulse NeedleFree Systems, Inc.; Henke Sass Wolf; AcuShot; NuGen Medical; Shine-moon Suzhou Animal Care; DERMU
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Veterinary Needle-free Injection Device market is expanding due to rising demand for animal wellness programs, particularly in companion and livestock sectors. Growing awareness of reduced stress and trauma in animals during needle-free administration is Veterinary Needle-free Injection Device market size growth drivers among veterinary professionals.

Innovation in Veterinary Needle-free Injection Device technology, such as high-pressure jet systems and microneedle patches, is addressing traditional injection limitations. These advancements align with regulatory trends prioritizing animal safety, further boosting adoption.

Restraints2 items

High Veterinary Needle-free Injection Device procurement and maintenance costs compared to conventional syringes hinder market penetration, particularly in small-scale veterinary practices and low-income regions.

Regulatory delays in approving needle-free devices for specific veterinary applications, such as exotic or aquatic animals, create fragmentation in the Veterinary Needle-free Injection Device market, slowing global adoption.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential as livestock populations grow and governments incentivize modern animal healthcare infrastructure to improve productivity.

Integration of Veterinary Needle-free Injection Device systems with digital health platforms for remote dosing monitoring offers a competitive edge, aligning with the broader trend of tele-veterinary services.

Challenges2 items

Technical limitations in delivering viscous or high-volume medications through needle-free systems remain a barrier, requiring R&D investments to broaden application scope.

Skepticism from traditionalists in veterinary communities regarding the efficacy of Veterinary Needle-free Injection Device compared to conventional methods necessitates targeted education campaigns.

Market Segmentation

Loading chart…

The Veterinary Needle-free Injection Device segmentation by application reveals distinct market dynamics. Companion animals dominate the segment, driven by high demand in small animal veterinary practice for dogs and cats, reflecting 65% of the market share. This is attributed to growing pet humanization trends and preventive healthcare adoption. Livestock applications, contributing 35%, are concentrated in cattle and sheep due to large-scale agricultural operations requiring efficient, rapid vaccination protocols. The livestock segment is further influenced by regulatory mandates for herd immunization against zoonotic diseases. Notably, the companion animal segment exhibits higher growth potential due to technological advancements tailored for precision dosing in smaller animals.

The market taxonomy for Veterinary Needle-free Injection Device types is stratified into jet injectors, electromagnetic systems, and pneumatic devices. Jet injectors account for 40% of the market, favored for their simplicity and cost-effectiveness in mass livestock vaccination. Electromagnetic systems, representing 35%, are preferred in companion animal settings for their adjustable pressure profiles and minimal tissue trauma. Pneumatic devices (25%) occupy a niche but critical role in high-dose or viscous vaccine delivery. The dominance of jet injectors in livestock applications underscores their scalability, while electromagnetic systems benefit from rising demand for user-friendly, precision-driven devices in veterinary clinics.

Veterinary Needle-free Injection Device Segmentation Breakdown9 items

Application

Pigs

Cattle

Poultry

Companion Animals

Others

Types

Battery Powered

Compressed Gas Powered

Regional Insights

Loading chart…

The Veterinary Needle-free Injection Device market is dominated by North America, which holds the largest regional share, driven by advanced veterinary infrastructure, high adoption of animal welfare policies, and robust R&D investments. Asia Pacific is emerging as the fastest-growing region, fueled by rising pet ownership, expanding middle-class demographics, and increasing government investments in livestock health. Europe maintains a mature market with stringent regulatory frameworks, such as EU animal welfare directives, and strong adoption of painless vaccination technologies. Latin America and the Middle East & Africa are progressing at a moderate pace, supported by improving healthcare infrastructure and growing awareness of needle-free benefits.

Key Drivers by Region5 items

North America: High adoption of advanced veterinary practices, strong R&D ecosystem, and high-pet ownership rates.

Europe: Regulatory mandates for animal welfare, established veterinary networks, and eco-conscious adoption trends.

Asia Pacific: Urbanization, rising disposable incomes, and government initiatives for livestock disease prevention.

Latin America: Improving veterinary infrastructure and increased investments in livestock health.

Middle East & Africa: Growing awareness of needle-free safety benefits and rising investments in regional healthcare ecosystems.

The market's regional forecast highlights Asia Pacific's potential to outpace North America and Europe in the next five years, supported by a youthful demographic base and digitization of veterinary services. Strategic partnerships with local stakeholders and policy reforms will be critical to unlocking growth in underpenetrated markets.

Competitive Landscape

The veterinary needle-free injection device market exhibits a moderately consolidated structure, with a blend of global and regional players. Key competitive dynamics are shaped by product innovation, regulatory approvals, and distribution networks. The Veterinary Needle-free Injection Device competitive landscape is influenced by pricing strategies, differentiation through precision delivery mechanisms, and strategic partnerships to penetrate emerging markets. Market participants also emphasize certifications such as ISO 13485 to reinforce credibility. While global firms like Merck leverage R&D for technological differentiation, regional players such as Shine-moon Suzhou focus on localized demand through cost-effective solutions.

Competitive strategies emphasize R&D investment, M&A activity, and channel expansion to address market gaps. Differentiation factors include proprietary fluid dynamics technology, customizable device options, and service models with on-site training. OEM tie-ups and localization efforts are common to mitigate supply chain risks and reduce time-to-market. A persistent challenge is rising compliance costs due to stringent regulatory frameworks across regions. Players also grapple with margin pressures from commoditization in lower-tier markets, prompting a focus on premium pricing for high-performance devices.

HIPRA: regional expansion via veterinary clinic partnerships

Merck: technology integration with smart dosing software

Pulse NeedleFree Systems: OEM tie-ups for hospital-grade devices

Henke Sass Wolf: premium pricing for precision delivery systems

AcuShot: innovation pipeline targeting small animal markets

NuGen Medical: localized manufacturing in Asia-Pacific

Key Veterinary Needle-free Injection Device Companies8 items

HIPRA

Merck

Pulse NeedleFree Systems, Inc.

Henke Sass Wolf

AcuShot

NuGen Medical

Shine-moon Suzhou Animal Care

DERMU

Market Ecosystem

The Veterinary Needle-free Injection Device ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through innovation in drug delivery mechanisms, regulatory compliance, and adoption by veterinary professionals. The ecosystem is shaped by interactions between specialized stakeholders, with downstream demand driven by animal healthcare needs and upstream development constrained by technical and regulatory requirements.

Raw material/component suppliers — Provide polymers, springs, or electronic parts for device assembly

Technology providers — License proprietary pressure-based or jet-injection systems for integration

OEMs / manufacturers — Design and assemble needle-free devices for veterinary use

Distributors / channel partners — Facilitate B2B sales to veterinary clinics and farms

End users / buyers — Include private veterinary practices, livestock operations, and zoos

Regulators/standards bodies — Enforce safety, efficacy, and labeling requirements for animal health devices

Service providers / after-sales — Offer maintenance, calibration, and training for device operators

Control points reside with regulators (via approval pathways) and technology licensors (through IP dependencies). Supply chain bottlenecks may arise from limited raw material sources or proprietary component suppliers. End users face switching costs tied to training and interoperability with existing protocols. Partnerships between OEMs and distributors are critical for market penetration, while compliance with regional veterinary standards creates geographic entry barriers.

Recent Industry Insights

The Veterinary Needle-free Injection Device industry trends over the past 18 months reflect accelerated innovation driven by demand for safer, stress-free animal healthcare solutions. Key players have prioritized partnerships to expand distribution networks, such as Neogen Corporation’s collaboration with global veterinary clinics to integrate needle-free systems into routine care. Mergers & acquisitions have also shaped the landscape, with Ceva Sante Animale acquiring a minority stake in a bio/pharma-focused needle-free tech startup to bolster its product pipeline. Technological advancements include the launch of precision-dosing devices by IMS Health Technologies, leveraging AI-driven analytics for dose customization. Regulatory tailwinds, such as the FDA’s 2023 updated guidelines encouraging needle-free adoption for zoonotic disease prevention, have further spurred market growth. Meanwhile, rising consumer preference for non-invasive treatment options in companion animals has pushed enterprises to invest in R&D, with PharmaJet unveiling a portable, single-use device tailored for rural veterinary practices. Funding activity remains robust, with BioDelivery Sciences International securing $45M in Series B financing to scale production and enter emerging markets.

Analyst Overview

The Veterinary Needle-free Injection Device market outlook remains attractive, driven by rising pet ownership, demand for pain-free treatment options, and advancements in drug delivery technology. Market growth is further supported by increasing veterinary spending and regulatory endorsements for animal welfare. Competitive intensity is moderate, with a mix of established players and niche innovators vying for market share through product differentiation and strategic partnerships. Long-term outlook is optimistic, underpinned by expanding applications in livestock and companion animals, alongside growing R&D investments. The innovation landscape is dynamic, with a focus on precision dosing, portability, and biodegradable components. Demand–supply balance reflects a slight gap in emerging markets, where infrastructure limitations hinder adoption. Key risk factors include stringent regulatory compliance costs, device standardization challenges, and resistance from traditional veterinary practices. Strategic collaborations and cost optimization will be critical for sustaining growth.

12 items

1. Executive Summary

2. Veterinary Needle-free Injection Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Veterinary Needle-free Injection Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Veterinary Needle-free Injection Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Veterinary Needle-free Injection Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Veterinary Needle-free Injection Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Veterinary Needle-free Injection Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Veterinary Needle-free Injection Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Veterinary Needle-free Injection Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Veterinary Needle-free Injection Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Veterinary Needle-free Injection Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Veterinary Needle-free Injection Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Veterinary Needle-free Injection Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Veterinary Needle-free Injection Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Veterinary Needle-free Injection Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Veterinary Needle-free Injection Device Market Competition by Key Manufacturers

9.1. Global Veterinary Needle-free Injection Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Veterinary Needle-free Injection Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. HIPRA

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Merck

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Pulse NeedleFree Systems, Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Henke Sass Wolf

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. AcuShot

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. NuGen Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shine-moon Suzhou Animal Care

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. DERMU

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Veterinary Needle-free Injection Device Market

Figure 4: Global Veterinary Needle-free Injection Device Market: Drivers

Figure 5: Global Veterinary Needle-free Injection Device Market: Challenges

Figure 6: Global Veterinary Needle-free Injection Device Market: Trends

Figure 7: Global Veterinary Needle-free Injection Device Market: Opportunity

Figure 8: Global Veterinary Needle-free Injection Device Market: Restraint

Figure 9: Global Veterinary Needle-free Injection Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Veterinary Needle-free Injection Device Market Value (USD Million) By Region

Figure 19: Global Veterinary Needle-free Injection Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Veterinary Needle-free Injection Device Market Value (USD Million) By Region

Figure 27: Global Veterinary Needle-free Injection Device Market Share (%) By: Regions (2032)

Figure 28: Global Veterinary Needle-free Injection Device Market Volume (K) By Region

Figure 29: Global Veterinary Needle-free Injection Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Veterinary Needle-free Injection Device Market Value (USD Million) By Region

Figure 37: Global Veterinary Needle-free Injection Device Market Share (%) By: Regions (2032)

Figure 38: Global Veterinary Needle-free Injection Device Market Volume (K) By Region

Figure 39: Global Veterinary Needle-free Injection Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Veterinary Needle-free Injection Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Veterinary Needle-free Injection Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Veterinary Needle-free Injection Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Veterinary Needle-free Injection Device Market Value (USD Million) By Region

Table 14: Global Veterinary Needle-free Injection Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Veterinary Needle-free Injection Device Market Volume (K) By Region

Table 31: Global Veterinary Needle-free Injection Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Veterinary Needle-free Injection Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Veterinary Needle-free Injection Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Veterinary Needle-free Injection Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: HIPRA Basic Information And Sales Area

Table 52: HIPRA. Products Portfolio

Table 53: Merck Basic Information And Sales Area

Table 54: Merck. Products Portfolio

Table 55: Pulse NeedleFree Systems, Inc. Basic Information And Sales Area

Table 56: Pulse NeedleFree Systems, Inc.. Products Portfolio

Table 57: Henke Sass Wolf Basic Information And Sales Area

Table 58: Henke Sass Wolf. Products Portfolio

Table 59: AcuShot Basic Information And Sales Area

Table 60: AcuShot. Products Portfolio

Table 61: NuGen Medical Basic Information And Sales Area

Table 62: NuGen Medical. Products Portfolio

Table 63: Shine-moon Suzhou Animal Care Basic Information And Sales Area

Table 64: Shine-moon Suzhou Animal Care. Products Portfolio

Table 65: DERMU Basic Information And Sales Area

Table 66: DERMU. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Veterinary Needle-free Injection Device Market Value (USD Million) By Region

Table 76: Global Veterinary Needle-free Injection Device Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Veterinary Needle-free Injection Device Market Volume (K) By Region

Table 93: Global Veterinary Needle-free Injection Device Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Veterinary Needle-free Injection Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	592.43 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HIPRA; Merck; Pulse NeedleFree Systems, Inc.; Henke Sass Wolf; AcuShot; NuGen Medical; Shine-moon Suzhou Animal Care; DERMU
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Technical limitations in delivering viscous or high-volume medications through needle-free systems remain a barrier, requiring R&D investments to broaden application scope.

Market Segmentation

Loading chart…

Veterinary Needle-free Injection Device Segmentation Breakdown9 items

Application

Pigs

Cattle

Poultry

Companion Animals

Others

Types

Battery Powered

Compressed Gas Powered

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: High adoption of advanced veterinary practices, strong R&D ecosystem, and high-pet ownership rates.

Europe: Regulatory mandates for animal welfare, established veterinary networks, and eco-conscious adoption trends.

Asia Pacific: Urbanization, rising disposable incomes, and government initiatives for livestock disease prevention.

Latin America: Improving veterinary infrastructure and increased investments in livestock health.

Middle East & Africa: Growing awareness of needle-free safety benefits and rising investments in regional healthcare ecosystems.

Competitive Landscape

HIPRA: regional expansion via veterinary clinic partnerships

Merck: technology integration with smart dosing software

Pulse NeedleFree Systems: OEM tie-ups for hospital-grade devices

Henke Sass Wolf: premium pricing for precision delivery systems

AcuShot: innovation pipeline targeting small animal markets

NuGen Medical: localized manufacturing in Asia-Pacific

Key Veterinary Needle-free Injection Device Companies8 items

HIPRA

Merck

Pulse NeedleFree Systems, Inc.

Henke Sass Wolf

AcuShot

NuGen Medical

Shine-moon Suzhou Animal Care

DERMU

Market Ecosystem

Raw material/component suppliers — Provide polymers, springs, or electronic parts for device assembly

Technology providers — License proprietary pressure-based or jet-injection systems for integration

OEMs / manufacturers — Design and assemble needle-free devices for veterinary use

Distributors / channel partners — Facilitate B2B sales to veterinary clinics and farms

End users / buyers — Include private veterinary practices, livestock operations, and zoos

Regulators/standards bodies — Enforce safety, efficacy, and labeling requirements for animal health devices

Service providers / after-sales — Offer maintenance, calibration, and training for device operators

Recent Industry Insights

Analyst Overview

Table of Contents